Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,440,213
+$622,443 QoQ
Shares Held
96,811
-1.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#664
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. MRK ranks #2 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
|
2,000 | $432,120 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,440,213 | 96,811 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,817,770 | 98,244 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,335,795 | 98,193 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,367,821 | 99,700 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,944,101 | 100,355 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,686,164 | 96,771 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,716,112 | 97,669 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,166,581 | 98,332 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,222,031 | 98,724 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $13,309,004 | 100,864 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $11,242,469 | 103,123 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $10,669,943 | 103,642 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,136,143 | 105,175 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $11,271,062 | 105,941 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,875,089 | 107,031 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,401,634 | 109,169 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,984,391 | 109,514 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,234,399 | 112,546 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,483,971 | 110,699 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,408,940 | 111,955 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,874,412 | 114,111 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,715,800 | 113,060 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,369,367 | 114,540 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $9,757,413 | 117,630 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,366,600 | 121,125 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $9,607,416 | 124,869 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||